UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 247

Sortiert nach

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Cellular physiology and biochemistry, 2018-01, Vol.51 (4), p.1518-1532

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of estrogen receptor phosphorylation

Endocrine-related cancer, 2011-02, Vol.18 (1), p.R1-R14

2011

Link zum Volltext

Verfügbarkeit prüfen

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

Nucleic acids research, 2009-07, Vol.37 (13), p.4518

2009

Link zum Volltext

Verfügbarkeit prüfen

Claudin 1 expression in basal-like breast cancer is related to patient age

BMC cancer, 2013-05, Vol.13 (1), p.268-268, Article 268

2013

Link zum Volltext

Verfügbarkeit prüfen

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

iScience, 2019-09, Vol.19, p.388-401

2019

Link zum Volltext

Verfügbarkeit prüfen

A robust cell culture system for large scale feeder cell-free expansion of human breast epithelial progenitors

Stem cell research & therapy, 2018-10, Vol.9 (1), p.264-264, Article 264

2018

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

The Journal of steroid biochemistry and molecular biology, 2008-03, Vol.109 (1), p.1-10

2008

Link zum Volltext

Verfügbarkeit prüfen

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Endocrine-related cancer, 2006-06, Vol.13 (2), p.327-334

2006

Link zum Volltext

Verfügbarkeit prüfen

Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.207-214

2003

Link zum Volltext

Verfügbarkeit prüfen

A bi-faceted role of estrogen receptor β in breast cancer

Endocrine-related cancer, 2013-06, Vol.20 (3), p.R127-R139

2013

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue

Stem cell reports, 2018-01, Vol.10 (1), p.196-211

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

Cancer epidemiology, biomarkers & prevention, 2008-12, Vol.17 (12), p.3344-3350

2008

Link zum Volltext

Verfügbarkeit prüfen

The role of estrogen receptor-β in breast cancer

Seminars in reproductive medicine, 2012-01, Vol.30 (1), p.5

2012

Link zum Volltext

Verfügbarkeit prüfen

Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression

Clinical cancer research, 2002-06, Vol.8 (6), p.1747-1753

2002

Link zum Volltext

Verfügbarkeit prüfen

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Endocrine-related cancer, 2010-09, Vol.17 (3), p.589-597

2010

Link zum Volltext

Verfügbarkeit prüfen

Recurrent copy number alterations in young women with breast cancer

Oncotarget, 2018-02, Vol.9 (14), p.11541-11558

2018

Link zum Volltext

Verfügbarkeit prüfen

Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen

Clinical cancer research, 2004-09, Vol.10 (17), p.5902-5906

2004

Link zum Volltext

Verfügbarkeit prüfen

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Cancer letters, 2016-08, Vol.378 (2), p.69-79

2016

Link zum Volltext

Verfügbarkeit prüfen

S100A7 and the progression of breast cancer

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.153-159, Article 153

2004

Link zum Volltext

Verfügbarkeit prüfen

The Prohibitins: emerging roles in diverse functions

Journal of cellular and molecular medicine, 2006-04, Vol.10 (2), p.353-363

2006

Link zum Volltext

Verfügbarkeit prüfen

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

Analytical chemistry (Washington), 2010-07, Vol.82 (13), p.5610-5620

2010

Link zum Volltext

Verfügbarkeit prüfen

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Endocrine-related cancer, 2015-08, Vol.22 (4), p.505-517

2015

Link zum Volltext

Verfügbarkeit prüfen

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma

Clinical cancer research, 2004-12, Vol.10 (24), p.8720-8727

2004

Link zum Volltext

Verfügbarkeit prüfen

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

Endocrine-related cancer, 2012-04, Vol.19 (2), p.181-195

2012

Link zum Volltext

Verfügbarkeit prüfen

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5696-5702

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Englisch
(247)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Clinical significance of estrogen receptor phosphorylation

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides

Claudin 1 expression in basal-like breast cancer is related to patient age

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

A robust cell culture system for large scale feeder cell-free expansion of human breast epithelial progenitors

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer

A bi-faceted role of estrogen receptor β in breast cancer

Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue

Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research

The role of estrogen receptor-β in breast cancer

Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Recurrent copy number alterations in young women with breast cancer

Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

S100A7 and the progression of breast cancer

The Prohibitins: emerging roles in diverse functions

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

Suchergebnisse filtern